Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
McKesson
Express Scripts
Harvard Business School
AstraZeneca

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tesaglitazar

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Tesaglitazar?

Tesaglitazar is an investigational drug.

There have been 17 clinical trials for Tesaglitazar. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 2004.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Insulin Resistance. The leading clinical trial sponsors are AstraZeneca and [disabled in preview].

Recent Clinical Trials for Tesaglitazar
TitleSponsorPhase
GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 DiabetesAstraZenecaPhase 3
ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin SensitivityAstraZenecaPhase 2
GALLANT 22 Tesaglitazar vs. PlaceboAstraZenecaPhase 3

See all Tesaglitazar clinical trials

Clinical Trial Summary for Tesaglitazar

Top disease conditions for Tesaglitazar
Top clinical trial sponsors for Tesaglitazar

See all Tesaglitazar clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Express Scripts
Moodys
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.